This was motivated by our observation that HABN administered IV accumulated in tumor cells and TAMCs in vivo (Fig. 1), potentially due to the interaction between HA coating of HABN and its ligand CD44 (Fig. 1i–l, Supplementary Figs. 5–7)41. The gene discussed is CD44; the disease is neoplasm.